MODERATE TO SEVERE ATOPIC DERMATITIS
Clinical trials for MODERATE TO SEVERE ATOPIC DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE ATOPIC DERMATITIS trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE ATOPIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New capsule trial targets severe eczema itch and rash
Disease control Not yet recruitingThis study is testing whether QLS12010 capsules can safely reduce the severity of eczema and itching in adults with moderate-to-severe atopic dermatitis. About 160 participants will receive either the experimental capsules or a placebo for 16 weeks to compare results. The trial a…
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New pill could offer relief for severe eczema sufferers
Disease control Not yet recruitingThis study is testing whether a new oral tablet called LW402 can safely reduce the severity of moderate-to-severe eczema (atopic dermatitis) in adults. About 480 participants will be randomly assigned to receive either the real tablet or a placebo pill for 16 weeks. The main goal…
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE3 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New drug tested for stubborn eczema that resists creams
Disease control Not yet recruitingThis study is testing an experimental oral medication called CMS-D001 for adults with moderate to severe eczema (atopic dermatitis) that hasn't responded well to standard creams. About 160 participants will be randomly assigned to receive one of three different doses of the drug …
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Dermavon Holdings Limited • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC